NHS weight-loss injections: who may qualify and how access works in the UK
NHS weight-loss injections are usually considered only for people in the UK who meet specific clinical criteria, including a suitable BMI and, in some cases, weight-related health conditions. Access can also depend on whether previous weight-management support has been tried and whether a specialist assessment is needed. Pathways may vary by area and current NHS guidance, so eligibility is not automatic. Private treatment may follow a different process, making it important to check up-to-date advice with a healthcare professional.
In the UK, weight-loss injections are prescription-only medicines. They are not available over the counter, and they are not intended as a quick fix. The NHS approach is tightly controlled by national guidance from NICE and by local service capacity. This means that even when someone meets the clinical criteria, access can depend on where they live and whether a specialist service has the resources to accept a referral.
What are the NHS eligibility criteria for weight-loss injections?
NICE guidance sets out who may be considered for semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro) for weight management. For semaglutide and tirzepatide, adults usually need a BMI of at least 35 with at least one weight-related condition, or a BMI of 30 to 34.9 with at least one weight-related condition. In the lower BMI range, treatment must be provided through a specialist weight-management service. Liraglutide has slightly different criteria. The medicines are prescribed alongside a reduced-calorie diet and increased physical activity. They are not for people who are pregnant or breastfeeding, and they are not a substitute for lifestyle changes.
BMI thresholds and related health conditions
BMI is a starting point, not the whole picture. Related health conditions can include type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnoea, and non-alcoholic fatty liver disease. Some guidance also mentions non-diabetic hyperglycaemia for liraglutide. A GP or specialist will consider medical history, current medicines, and any risk factors. BMI thresholds are used to identify people who may benefit most, but they are not a diagnosis. Waist circumference, ethnicity, and other clinical factors can also influence assessment. For people with a lower BMI, the presence of a weight-related condition is often essential for NHS access.
Previous weight-management support and referral steps
NHS access usually begins with a conversation with a GP or practice nurse. They may ask about previous attempts to manage weight through diet, exercise, or other programmes. In many cases, a referral to a specialist weight-management service is needed before a weight-loss injection can be prescribed. These services are sometimes called tier 3 or tier 4 services. Waiting times vary by area. Some people may be offered behavioural support, dietetic advice, or other treatments first. If a referral is accepted, a specialist team will assess whether a weight-loss injection is suitable. The medicine is then prescribed and monitored, often with regular reviews.
How NHS access differs from private treatment
Private treatment is available through online pharmacies, private clinics, and some high-street pharmacies. Private providers may have different eligibility rules, and some offer remote consultations. Access can be faster, but the patient pays the full cost. NHS treatment is based on clinical need and is free at the point of use in Scotland, Wales, and Northern Ireland. In England, there is usually a prescription charge unless the person is exempt. NHS supply is also limited by specialist service capacity and phased rollout arrangements, especially for tirzepatide. Private providers may not have the same multidisciplinary support, and ongoing monitoring can vary.
Costs and private providers compared
Real-world costs for weight-loss injections vary by medicine, dose, provider, and whether treatment is NHS or private. NHS patients in England typically pay the standard prescription charge of £9.90 per item, although many people are exempt. In Scotland, Wales, and Northern Ireland, NHS prescriptions are free. Private treatment usually involves a monthly fee that covers the medicine, consultation, and delivery. Prices can change, and some providers charge extra for support or blood tests. The table below gives an overview of common options and estimated costs.
| Product/Service | Provider | Cost Estimation |
|---|---|---|
| Wegovy (semaglutide) | NHS specialist weight management service | £9.90 per prescription item in England; free in Scotland, Wales, and Northern Ireland |
| Wegovy (semaglutide) | Boots Online Doctor | Typically £150–£300 per month, depending on dose |
| Saxenda (liraglutide) | NHS specialist weight management service | £9.90 per prescription item in England; free in Scotland, Wales, and Northern Ireland |
| Saxenda (liraglutide) | Superdrug Online Doctor | Typically £120–£250 per month, depending on dose |
| Mounjaro (tirzepatide) | NHS specialist weight management service | Subject to phased rollout; prescription charge rules apply |
| Mounjaro (tirzepatide) | LloydsPharmacy Online Doctor | Typically £180–£350 per month, depending on dose |
Prices, rates, or cost estimates mentioned in this article are based on the latest available information but may change over time. Independent research is advised before making financial decisions.
NHS weight-loss injections are available only within specific clinical criteria and usually through specialist weight-management services. BMI, related health conditions, previous weight-management support, and local service capacity all play a role. Private treatment offers another route, but it comes with different costs and levels of support. Anyone considering these medicines should speak to a qualified healthcare professional to discuss their own situation and the most appropriate option.
This article is for informational purposes only and should not be considered medical advice. Please consult a qualified healthcare professional for personalized guidance and treatment.